Market Snapshot
S&P Futures
3,809.5
Dow Futures
30,868
Nasdaq Futures
11,633.25
Biodesix, Inc. (BDSX) stock rallied over 21.48% intraday to trade at $1.64 a share on NASDAQ. The stock opened with a gain of 18.84% at $1.3 and touched an intraday high of $1.65, rising 21.48% against the last close of $1.35. The stock went to a low of $1.3 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-06-30 | $1.3 | $1.65 | $1.3 | $1.64 | 317,400 |
2022-06-29 | $1.38 | $1.39 | $1.28 | $1.35 | 77,900 |
2022-06-28 | $1.33 | $1.39 | $1.31 | $1.37 | 82,600 |
2022-06-27 | $1.33 | $1.4 | $1.28 | $1.35 | 122,800 |
2022-06-24 | $1.4 | $1.42 | $1.34 | $1.35 | 1,284,500 |
2022-06-23 | $1.34 | $1.4 | $1.33 | $1.39 | 157,600 |
2022-06-22 | $1.37 | $1.39 | $1.325 | $1.34 | 150,800 |
2022-06-21 | $1.53 | $1.53 | $1.3 | $1.33 | 227,300 |
2022-06-17 | $1.5 | $1.543 | $1.45 | $1.455 | 135,700 |
2022-06-16 | $1.64 | $1.64 | $1.42 | $1.52 | 124,200 |
Employees-
Beta-
Sales or Revenue54.51 Million
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryHealth Care Services
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung cancer continuum of care, such as Nodify XL2 and Nodify CDT tests to help physicians reclassify risk of malignancy in patients with suspicious lung nodules; and GeneStrat tumor profiling and VeriStrat immune profiling tests that provide physicians with timely results to facilitate treatment decisions. It also provides Bio-Rad SARS-CoV-2 ddPCR test, which is designed to detect the presence of infection by the SARS-CoV-2 virus; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. In addition, the company offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.
Biodesix, Inc. (NASDAQ: BDSX) stock price is $1.64 as of the last check on Thursday, June 30. During the trading session, BDSX stock reached the peak price of $1.65 while $1.3 was the lowest point it dropped to.
The NASDAQ listed BDSX is part of Health Care Services industry that operates in the broader Health Care sector. Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States.
Mr. Kieran O'Kane
Chief Commercial Officer
Mr. Scott Hutton
Pres, CEO & Director
Ms. Robin Harper Cowie
CFO, Sec. & Treasurer
Mr. Ryan H. Siurek
Chief Accounting Officer
BDSX stock traded closed the last session at $1.64, which is $0.29 or 21.48% lower than its previous close of $1.35. BDSX's current trading price is 31.20% lower than its 52-week high of $13.89 where as its distance from 52-week low of 1.25% is -88.19%.
Number of BDSX employees currently stands at -. BDSX operates from 2970 Wilderness Place, Suite 100, Boulder, CO 80301, United States.
Official Webiste of $BDSX is: https://www.biodesix.com
BDSX could be contacted at BDSX operates from 2970 Wilderness Place, Suite 100, Boulder, CO 80301, United States, or at phone #303 417 0500 and can also be accessed through its website.
BDSX stock volume for the day was 317,693 shares while in the previous session number of BDSX shares traded was 317,400 . The average number of BDSX shares traded daily for last 3 months was 617.49 Thousands.
The percentage change in BDSX stock occurred in the recent session was 21.48% while the dollar amount for the price change in BDSX stock was $0.29.
In the recent session, the day high for BDSX stock was $1.65 while the low for BDSX stock touched on the day was $1.3.
The market value of BDSX currently stands at 67.17 Million with its latest stock price at $1.64 and 31.07 Million of its shares outstanding.